chr2-166196045-CTTAAAAAAGTT-C
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_001365536.1(SCN9A):c.*2616_*2626del variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.482 in 151,348 control chromosomes in the GnomAD database, including 17,861 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.48 ( 17859 hom., cov: 0)
Exomes 𝑓: 0.50 ( 2 hom. )
Consequence
SCN9A
NM_001365536.1 3_prime_UTR
NM_001365536.1 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.70
Genes affected
SCN9A (HGNC:10597): (sodium voltage-gated channel alpha subunit 9) This gene encodes a voltage-gated sodium channel which plays a significant role in nociception signaling. Mutations in this gene have been associated with primary erythermalgia, channelopathy-associated insensitivity to pain, and paroxysmal extreme pain disorder. [provided by RefSeq, Aug 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 2-166196045-CTTAAAAAAGTT-C is Benign according to our data. Variant chr2-166196045-CTTAAAAAAGTT-C is described in ClinVar as [Benign]. Clinvar id is 331908.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.553 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN9A | NM_001365536.1 | c.*2616_*2626del | 3_prime_UTR_variant | 27/27 | ENST00000642356.2 | NP_001352465.1 | ||
SCN1A-AS1 | NR_110260.1 | n.432-3591_432-3581del | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN9A | ENST00000642356.2 | c.*2616_*2626del | 3_prime_UTR_variant | 27/27 | NM_001365536.1 | ENSP00000495601 | P1 | |||
SCN1A-AS1 | ENST00000651574.1 | n.1110-3591_1110-3581del | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.482 AC: 72888AN: 151206Hom.: 17854 Cov.: 0
GnomAD3 genomes
AF:
AC:
72888
AN:
151206
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.500 AC: 11AN: 22Hom.: 2 AF XY: 0.500 AC XY: 10AN XY: 20
GnomAD4 exome
AF:
AC:
11
AN:
22
Hom.:
AF XY:
AC XY:
10
AN XY:
20
Gnomad4 EAS exome
AF:
Gnomad4 NFE exome
AF:
GnomAD4 genome AF: 0.482 AC: 72916AN: 151326Hom.: 17859 Cov.: 0 AF XY: 0.476 AC XY: 35225AN XY: 73928
GnomAD4 genome
AF:
AC:
72916
AN:
151326
Hom.:
Cov.:
0
AF XY:
AC XY:
35225
AN XY:
73928
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1601
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inherited Erythromelalgia Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Generalized epilepsy with febrile seizures plus Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Congenital Indifference to Pain Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Small fiber neuropathy Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Paroxysmal extreme pain disorder Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Febrile seizures, familial Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Severe myoclonic epilepsy in infancy Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at